• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG GAV 2.0 VALVE 5/25; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG GAV 2.0 VALVE 5/25; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX211T
Medical Device Problem Code Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 10/23/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturing site evaluation: no product received to date.Should relevant additional information/investigation results become available, an additional medwatch report will be submitted.
 
Event or Problem Description
It was reported that a gav 2.0 ventil 10/25 (#fx214t) was implanted during a procedure performed on unknown.According to the complainant, the shunt showed a blockage.The patient underwent a revision procedure performed on unknown.The complainant device has not yet returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.
 
Additional Manufacturer Narrative
Correction/ adaption: d1 + d4.Investigation: visual inspection: during the investigation, no significant deformations or damage of the valve was determined.Permeability test: a permeability test has shown that the valve has a blockage.Computer controlled test: the test is not applicable, due to the determined blockage.Internal inspection : after dismantling of the valve, some visible deposits were found in gav 2.0.Results: based on our investigation results, we can determine a blockage in the valve.The determined deposits can be named as the cause for the occlusion.Organic material in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event or Problem Description
Correction: a gav 2.0 valve (#fx211t) was effected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GAV 2.0 VALVE 5/25
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key18409554
Report Number3004721439-2023-00390
Device Sequence Number2690677
Product Code JXG
UDI-Device Identifier04041906500016
UDI-Public4041906500016
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K190174
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/22/2025
Device Model NumberFX211T
Device Catalogue NumberFX211T
Device Lot Number20048478
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/04/2023
Supplement Date Received by Manufacturer01/12/2024
Initial Report FDA Received Date12/28/2023
Supplement Report FDA Received Date01/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/23/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age4 YR
Patient SexMale
Patient Weight17 KG
-
-